iBio (IBIO) FCF Margin Growth (3y) (2014 - 2024)
iBio (IBIO) FCF Margin Growth (3y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -3,088.00 |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -91,001.00 |
| Sep 30, 2023 | -885,341.00 |
| Mar 31, 2022 | 44,292.00 |
| Sep 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | 196,904.00 |
| Mar 31, 2021 | 395,441.00 |
| Dec 31, 2020 | 112,822.00 |
| Sep 30, 2020 | 72,505.00 |
| Jun 30, 2020 | 249,356.00 |
| Mar 31, 2020 | 633,843.00 |
| Dec 31, 2019 | 378,861.00 |
| Sep 30, 2019 | -13,759.00 |
| Jun 30, 2019 | 47,743.00 |
| Mar 31, 2019 | -16,538.00 |
| Dec 31, 2018 | 47,295.00 |
| Sep 30, 2018 | -162,090.00 |
| Jun 30, 2018 | -357,142.00 |
| Mar 31, 2018 | -466,522.00 |
| Dec 31, 2017 | -202,089.00 |
| Sep 30, 2017 | -248,033.00 |